Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia

• Published in: Clinical and experimental medicine Vol. 23; no. 4; pp. 1277 - 1284
• Main Authors: Pálinkás, Márton, Szabó, Edit, Kulin, Anna, Mózner, Orsolya, Rásonyi, Rita, Juhász, Péter, Nagy, Krisztina, Várady, György, Vörös, Dóra, Zámbó, Boglárka, Sarkadi, Balázs, Poór, Gyula
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.08.2023; Springer Nature B.V
• Subjects: ATP Binding Cassette Transporter, Subfamily G, Member 2 - genetics; ATP Binding Cassette Transporter, Subfamily G, Member 2 - metabolism; Comorbidity; Erythrocytes; Excretion; Flow cytometry; Gene polymorphism; Gout; Gout - drug therapy; Gout - genetics; Gout - metabolism; Hematology; Humans; Hyperuricemia; Hyperuricemia - drug therapy; Hyperuricemia - genetics; Internal Medicine; Medicine; Medicine & Public Health; Neoplasm Proteins - chemistry; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; Oncology; Original; Original Article; Patient Acuity; Polymorphism, Single Nucleotide; Protein expression; Proteins; Single-nucleotide polymorphism; Uric Acid; ABCG2 transporters; Genetics; Protein expression; Renal-overload hyperuricemia; Gout severity
• ISSN: 1591-9528; 1591-8890; 1591-9528
• DOI: 10.1007/s10238-022-00848-7

Gout is a common crystal induced disease of high personal and social burden, characterised by severe arthritis and comorbidity if untreated. Impaired function of ABCG2 transporter is causative in gout and may be responsible for renal-overload type hyperuricemia. Despite its importance, there is limited information on how clinical parameters correlate with protein expression and that with genetic changes. Urate and clinical parameters of 78 gouty patients and healthy controls were measured among standardised circumstances from a Hungarian population. ABCG2 membrane expression of red blood cells was determined by flow cytometry-based method and SNPs of this protein were analysed by TaqMan-based qPCR. The prevalence of ABCG2 functional polymorphisms in gouty and control patients were 32.1 and 13.7%, respectively. Most common SNP was Q141K while one sample with R236X, R383C and the lately described M71V were found in the gouty population. These polymorphisms showed strong linkage with decreased protein expression while the latter was also associated with higher fractional urate excretion (FUE) and urinary urate excretion (UUE). This study firstly evaluated ABCG2 protein expression in a clinically defined gouty population while also proving its associations between ABCG2 genetic changes and renal-overload hyperuricemia. The paper also highlighted relations between ABCG2 SNPs, gout susceptibility and disease severity characterised by an early onset disease with frequent flares and tophi formation.